Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jinsy A. Andrews, Carlayne E. Jackson, Terry D. Heiman-Patterson, Paolo Bettica, Benjamin Rix Brooks & Erik P. Pioro. (2020) Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 509-518.
Read now
Read now
Malgorzata Gawel, Magdalena Kuzma-Kozakiewicz, Elzbieta Szmidt-Salkowska & Anna Kamińska. (2014) Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:3-4, pages 257-261.
Read now
Read now
Giulio E. Lancioni, Nirbhay N. Singh, Mark F. O’Reilly, Jeff Sigafoos, Gabriele Ferlisi, Giacomina Ferrarese, Valeria Zullo & Doretta Oliva. (2014) A voice-sensitive microswitch for a man with amyotrophic lateral sclerosis and pervasive motor impairment. Disability and Rehabilitation: Assistive Technology 9:3, pages 260-263.
Read now
Read now
Giulio E. Lancioni, Nirbhay N. Singh, Mark F. O’Reilly, Vanessa A. Green, Gabriele Ferlisi, Giacomina Ferrarese, Valeria Zullo, Simona Schirone & Doretta Oliva. (2013) A man with amyotrophic lateral sclerosis uses a mouth pressure microswitch to operate a text messaging system with a word prediction function. Developmental Neurorehabilitation 16:5, pages 315-320.
Read now
Read now
Filippo Rossi, Giuseppe Perale, Simonetta Papa, Gianluigi Forloni & Pietro Veglianese. (2013) Current options for drug delivery to the spinal cord. Expert Opinion on Drug Delivery 10:3, pages 385-396.
Read now
Read now
Philippe Corcia & Paul H Gordon. (2012) Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole. Therapeutics and Clinical Risk Management 8, pages 359-366.
Read now
Read now
Articles from other publishers (24)
Entesar Yaseen Abdo Qaid, Zuraidah Abdullah, Rahimah Zakaria & Idris Long. (2022) Minocycline Protects Against Lipopolysaccharide-Induced Cognitive Impairment and Oxidative Stress: Possible Role of the CREB-BDNF Signaling Pathway. Neurochemical Research 48:5, pages 1480-1490.
Crossref
Crossref
Arnab Sarkar, Sanjukta Saha, Abhik Paul, Avik Maji, Puspita Roy & Tapan Kumar Maity. (2021) Understanding stem cells and its pivotal role in regenerative medicine. Life Sciences 273, pages 119270.
Crossref
Crossref
Jie Wang, Wei-Wei Hu, Zhi Jiang & Mei-Jiang Feng. (2020) Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. World Journal of Stem Cells 12:5, pages 323-338.
Crossref
Crossref
Filippo Rossi, Mario Gimona & Giuseppe Perale. 2020. Spinal Cord Injury (SCI) Repair Strategies. Spinal Cord Injury (SCI) Repair Strategies
307
312
.
Jennifer Glaser & Masatoshi Suzuki. 2018. Muscle Cell and Tissue - Current Status of Research Field. Muscle Cell and Tissue - Current Status of Research Field.
Ina Dervishi & P. Hande Ozdinler. (2018) Incorporating upper motor neuron health in ALS drug discovery. Drug Discovery Today 23:3, pages 696-703.
Crossref
Crossref
Paramita Chakrabarty & Jacob I. Ayers. 2018. Gene Therapy in Neurological Disorders. Gene Therapy in Neurological Disorders
229
246
.
Joanna Czarzasta, Aleksandra Habich, Tomasz Siwek, Adam Czapliński, Wojciech Maksymowicz & Joanna Wojtkiewicz. (2017) Stem cells for ALS: An overview of possible therapeutic approaches. International Journal of Developmental Neuroscience 57:1, pages 46-55.
Crossref
Crossref
Ke Li, Tamara J. Hala, Suneil Seetharam, David J. Poulsen, Megan C. Wright & Angelo C. Lepore. (2015) GLT1 overexpression in SOD1G93A mouse cervical spinal cord does not preserve diaphragm function or extend disease. Neurobiology of Disease 78, pages 12-23.
Crossref
Crossref
Catherine A. Blizzard, Katherine A. Southam, Edgar Dawkins, Katherine E. Lewis, Anna E. King, Jayden A. Clark & Tracey C. Dickson. (2015) Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis – vulnerability of lower motor neurons to proximal excitotoxicity. Disease Models & Mechanisms 8:3, pages 215-224.
Crossref
Crossref
M. Dadon-Nachum, K. Ben-Yaacov, T. Ben-Zur, Y. Barhum, D. Yaffe, E. Perlson & D. Offen. (2014) Transplanted Modified Muscle Progenitor Cells Expressing a Mixture of Neurotrophic Factors Delay Disease Onset and Enhance Survival in the SOD1 Mouse Model of ALS. Journal of Molecular Neuroscience 55:3, pages 788-797.
Crossref
Crossref
Nam-Hee KimMin Oh Lee. (2015) Update of Therapeutic Clinical Trials for Amyotrophic Lateral Sclerosis. Korean Journal of Clinical Neurophysiology 17:1, pages 1.
Crossref
Crossref
Christopher J Donnelly, Jonathan C Grima & Rita Sattler. (2014) Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?. Neurodegenerative Disease Management 4:6, pages 417-437.
Crossref
Crossref
H.-Q. Jiang, M. Ren, H.-Z. Jiang, J. Wang, J. Zhang, X. Yin, S.-Y. Wang, Y. Qi, X.-D. Wang & H.-L. Feng. (2014) Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 277, pages 132-138.
Crossref
Crossref
Christina M Lewis & Masatoshi Suzuki. (2014) Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis. Stem Cell Research & Therapy 5:2.
Crossref
Crossref
Raffaella Adami, Giuseppe Scesa & Daniele Bottai. (2014) Stem cell transplantation in neurological diseases: improving effectiveness in animal models. Frontiers in Cell and Developmental Biology 2.
Crossref
Crossref
Monica Nizzardo, Chiara Simone, Federica Rizzo, Margherita Ruggieri, Sabrina Salani, Giulietta Riboldi, Irene Faravelli, Chiara Zanetta, Nereo Bresolin, Giacomo P. Comi & Stefania Corti. (2014) Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Human Molecular Genetics 23:2, pages 342-354.
Crossref
Crossref
Anthony P. Nicholas, Liang Lu, Michael Heaven, Inga Kadish, Thomas van Groen, Mary Ann Accaviti-Loper, Sonja Wewering, Diane Kofskey, Pierluigi Gambetti & Michael Brenner. 2014. Protein Deimination in Human Health and Disease. Protein Deimination in Human Health and Disease
257
280
.
Xenia Kobeleva & Susanne Petri. (2013) Barriers to novel therapeutics in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 3:6, pages 525-537.
Crossref
Crossref
Merit E Cudkowicz, Leonard H van den Berg, Jeremy M Shefner, Hiroshi Mitsumoto, Jesus S Mora, Albert Ludolph, Orla Hardiman, Michael E Bozik, Evan W Ingersoll, Donald Archibald, Adam L Meyers, Yingwen Dong, Wildon R Farwell & Douglas A Kerr. (2013) Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. The Lancet Neurology 12:11, pages 1059-1067.
Crossref
Crossref
H. Hovden, J. L. Frederiksen & S. W. Pedersen. (2013) Immune system alterations in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica, pages n/a-n/a.
Crossref
Crossref
Anuradha Duleep & Jeremy Shefner. (2013) Electrodiagnosis of Motor Neuron Disease. Physical Medicine and Rehabilitation Clinics of North America 24:1, pages 139-151.
Crossref
Crossref
Waltteri Siirala, Tarja Saaresranta, Arno Vuori, Sanna Salanterä, Klaus T Olkkola & Riku Aantaa. (2012) Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study. BMC Palliative Care 11:1.
Crossref
Crossref
Frank S. Walsh & Julia Lynn Rutkowski. (2012) Myostatin as a therapeutic target in Amyotrophic Lateral Sclerosis. Neurochemistry International 61:6, pages 931-935.
Crossref
Crossref